Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of GBP 119.34 billion. The enterprise value is 161.07 billion.

Market Cap	119.34B
Enterprise Value	161.07B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Nov 18, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.42%
Shares Change (QoQ)	+0.18%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.16M

Valuation Ratios

The trailing PE ratio is 37.81.

PE Ratio	37.81
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 15.96, with an EV/FCF ratio of 34.36.

EV / Earnings	51.03
EV / Sales	6.10
EV / EBITDA	15.96
EV / EBIT	29.72
EV / FCF	34.36

Financial Position

The company has a current ratio of 1.32, with a Debt / Equity ratio of 8.02.

Current Ratio	1.32
Quick Ratio	0.80
Debt / Equity	8.02
Debt / EBITDA	4.86
Debt / FCF	9.61
Interest Coverage	2.07

Financial Efficiency

Return on equity (ROE) is 55.72% and return on invested capital (ROIC) is 6.13%.

Return on Equity (ROE)	55.72%
Return on Assets (ROA)	4.60%
Return on Capital (ROIC)	6.13%
Revenue Per Employee	909,124
Profits Per Employee	118,202
Employee Count	26,700
Asset Turnover	0.36
Inventory Turnover	2.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-10.60%
50-Day Moving Average	275.73
200-Day Moving Average	305.08
Relative Strength Index (RSI)	57.65
Average Volume (20 Days)	3,347

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.10

Income Statement

In the last 12 months, Amgen had revenue of GBP 24.27 billion and earned 3.16 billion in profits. Earnings per share was 5.84.

Revenue	24.27B
Gross Profit	14.71B
Operating Income	4.98B
Pretax Income	3.49B
Net Income	3.16B
EBITDA	9.14B
EBIT	4.98B
Earnings Per Share (EPS)	5.84

Full Income Statement

Balance Sheet

The company has 6.72 billion in cash and 45.06 billion in debt, giving a net cash position of -38.34 billion.

Cash & Cash Equivalents	6.72B
Total Debt	45.06B
Net Cash	-38.34B
Net Cash Per Share	n/a
Equity (Book Value)	5.62B
Book Value Per Share	10.45
Working Capital	4.82B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 5.41 billion and capital expenditures -726.70 million, giving a free cash flow of 4.69 billion.

Operating Cash Flow	5.41B
Capital Expenditures	-726.70M
Free Cash Flow	4.69B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 60.59%, with operating and profit margins of 20.51% and 13.00%.

Gross Margin	60.59%
Operating Margin	20.51%
Pretax Margin	14.38%
Profit Margin	13.00%
EBITDA Margin	37.64%
EBIT Margin	20.51%
FCF Margin	19.31%

Dividends & Yields

This stock pays an annual dividend of 7.09, which amounts to a dividend yield of 2.59%.

Dividend Per Share	7.09
Dividend Yield	2.59%
Dividend Growth (YoY)	3.54%
Years of Dividend Growth	6
Payout Ratio	112.70%
Buyback Yield	-0.42%
Shareholder Yield	2.19%
Earnings Yield	2.64%
FCF Yield	3.93%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.44. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.44
Piotroski F-Score	n/a